Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum Haemorrhage in All Births Excessive bleeding after birth, also known as postpartum haemorrhage (PPH), is the leading direct ...
Community-based treatment studies are now under way in Tanzania, Nigeria, and soon to start in Ethiopia and Bangladesh, conducted by the Venture Strategies for Health and Development group with ...
Letters: Prof Andrew Weeks, Anna Melamed and Sonia Richardson on the rising rate of postpartum haemorrhage, and the factors associated with it ...
Two simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research presented at the ANESTHESIOLOGY ® 2023 annual meeting. As the leading cause ...
Woman-in-Labor_G_962036740 Heat-stable carbetocin — an analog of oxytocin — was found to be noninferior to oxytocin in preventing hemorrhage associated with vaginal birth and may be beneficial in low- ...
Postpartum hemorrhage is the leading cause of maternal deaths in developing countries. This report highlights the social and cultural factors that influence the decision to seek care in cases of ...
MedPage Today on MSN
Burden of Postpartum Hemorrhage May Be Greater Than Previously Thought
The WHO defines postpartum hemorrhage, a major cause of maternal mortality, as blood loss of 500 mL or more in the first 24 ...
Industry Veterans Will Lead Planned Launch of Device Designed to Provide a Safe, Rapid Solution for Abnormal Postpartum Uterine Bleeding Proceeds will be used to support the anticipated U.S.
United States Data Bridge Market Research conducted an extensive qualitative study focusing on the “Postpartum Hemorrhage Treatment Devices Market“. The Postpartum Hemorrhage Treatment Devices market ...
The use of tranexamic acid reduces mortality due to postpartum hemorrhage. We investigated whether the prophylactic administration of tranexamic acid in addition to prophylactic oxytocin in women with ...
Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health Products (MAGHP) procedure, 3 which aims to build capacity and speed up access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results